Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPci-pal Regulatory News (PCIP)

Share Price Information for Pci-pal (PCIP)

Share Price is delayed by 15 minutes
Get Live Data
49.00    0.00 (0.00%)
Bid:
48.00
Ask:
50.00
Spread: 2.00 (4.167%)
Market Cap: £35.50m
PCIP Live PriceLast checked at - London Stock Exchange

Intraday Pci-pal Share Chart

Trading Update

16 Jul 2014 07:00

RNS Number : 4128M
IPPlus PLC
16 July 2014
Β 

For immediate release

16 July 2014

IPPLUS PLC

("IPPLUS" or the "Group")

Trading Update

IPPLUS PLC (AIM: IPP), the Ipswich based services company covering call centre services, call centre software, archiving, disaster recovery, telephony and payment card industry (PCI) compliant solutions, provides the following trading update for the financial year ended 30 June 2014. Comparable figures relate to the corresponding twelve-month period to 30 June 2013.

While the performance of the Group's different businesses has been mixed, the Board is pleased to be able to report that it expects IPPlus to report revenue of Β£9.1 million and profit before tax of Β£0.5 million for the full year (2013: Β£8.1 million and Β£0.35 million respectively). The substantially improved headline performance for 2014 does, however, include a one-off profit on lease surrender of Β£0.35 million arising from the purchase of the Company's first floor office space, as reported in the interim results.

The overall result reflects: a reasonably strong performance of the Group's Ansaback call centre division (incorporating IP3 Telecom), which continued to perform in line with the Board's expectations (with growth in both revenue and new contracts wins); a weaker than expected performance for CallScripter, the Group's software division; and, a loss for Ancora.

CallScripter sales for the recently ended period will show a reduction of approximately Β£0.4 million from the June 2013 sales level of approximately Β£1.5 million. This sales shortfall, as well as additional software division staffing and restructuring costs, will mean that growth elsewhere in the Group has been negated, resulting in a small overall loss for the Group in the second half of the year.

Looking ahead, the Group is aware that certain fixed seat fixed term call centre contracts will be ending in the current financial year and that the Ansaback sales team will be required to win additional new business to compensate for this.

The Group's cash position at 30 June 2014 of approximately Β£0.5m (2013 Β£0.6m) remained healthy and net indebtedness at that date was approximately Β£0.7m (including the building mortgage of approximately Β£1.2m).

Commenting for IPPLUS, Chief Executive Officer,Β William CatchpoleΒ said:

"It has been an excellent year for our call centre business whilst the prospects for our PCI solution and its sales pipeline are most encouraging. It is of course frustrating to have seen a reduction in the software divisional sales in the year, however, we anticipate that this will recover its momentum asΒ the CallScripter software is a market leader utilised in call centres around the world. The Group has good recurring revenue and an adequate capital position. The Board remains confident that the Company has good prospects ahead."

The Company expects to announce its final results for the year ended 30 June 2014 during the first half of September 2014.

For further information, please contact:

IPPLUS PLC

Tel: +44 (0)1473 321 800

William Catchpole, Chief Executive Officer

Stuart Gordon, Chief Financial Officer

Β 

N+1 Singer (Nomad & Broker)

Tel: +44 (0)20 7496 3000

Aubrey Powell

Alex Wright

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
MSCLLFFRDSIELIS
Date   Source Headline
14th Apr 20267:00 amRNS-RHIPAA, HITRUST & SOC 2 Type II certification
18th Mar 20267:00 amRNS-RMajor New Reseller Partnership with Global Telco
10th Mar 20263:07 pmRNSHolding(s) in Company
10th Mar 20263:07 pmRNSHolding(s) in Company
3rd Mar 20267:00 amRNSInterim Results, Analyst Briefing & Investor Pres
23rd Feb 20267:00 amRNS-RNew Major Strategic Reseller Partnership
17th Feb 20267:00 amRNSNotice of Results, Analyst Briefing, Investor Pres
10th Feb 20265:07 pmRNSHolding(s) in Company
6th Feb 202611:26 amRNSHolding(s) in Company
6th Feb 202611:25 amRNSHolding(s) in Company
5th Feb 202612:48 pmRNSHolding(s) in Company
3rd Feb 20267:00 amRNSTrading Update
18th Dec 20254:44 pmRNSGrant of Options under Long-Term Incentive Plan
18th Dec 20254:44 pmRNSGrant of Options under Long-Term Incentive Plan
1st Dec 20252:49 pmRNSResult of AGM
19th Nov 20257:00 amRNS-RStrategic US Healthcare Sector Integration
17th Nov 20253:19 pmRNS-RCMD Presentation Video
14th Nov 20257:00 amRNS-RCMD Presentation & MelloLondon
11th Nov 20257:00 amRNSCapital Markets Day
6th Nov 20254:20 pmRNSAnnual Financial Report & Notice of AGM
25th Sep 20258:45 amRNSHolding(s) in Company
9th Sep 20257:00 amRNSFinal Results, Analyst Briefing & Investor Pres
19th Aug 20257:00 amRNSNotice of Results, Analyst Briefing, Investor Pres
30th Jul 20253:18 pmRNSDirector Share Purchases
29th Jul 202510:20 amRNSDirector Share Purchase
29th Jul 20257:01 amRNSTrading & Business Update
29th Jul 20257:00 amRNSNew Product Launch
1st Jul 20257:00 amRNSBoard Changes
20th Jun 202512:00 pmRNSIssue of Equity & TVR
3rd Apr 20259:24 amRNSHolding(s) in Company
12th Mar 20253:20 pmRNSDirector Share Purchases
10th Mar 20257:00 amRNS-RPCI Pal and RingCentral Inc Partnership
6th Mar 20252:00 pmRNSPDMR Issue of Options
4th Mar 20253:49 pmRNSDirector Share Purchase
4th Mar 20257:00 amRNSInterim Results, Analyst Briefing & Investor Pres
18th Feb 20257:00 amRNSNotice of Results, Analyst Briefing, Investor Pres
27th Jan 20257:00 amRNSTrading Update
11th Dec 20242:42 pmRNSHolding(s) in Company
11th Dec 20242:17 pmRNSResult of AGM
11th Dec 20247:00 amRNSAGM Statement
6th Dec 20244:10 pmRNSExercise of Options & TVR
14th Nov 20244:23 pmRNSAnnual Financial Report & Notice of AGM
22nd Oct 20247:00 amRNSFinal Results, Analyst Briefing & Investor Pres
14th Oct 20247:00 amRNSConfirmation of CFO Appointment
19th Sep 20247:00 amRNSAudit Update & Timing of Results
10th Sep 20244:46 pmRNSHolding(s) in Company
28th Aug 20247:00 amRNSTrading Update, New Partner & Notice of Results
22nd Jul 20249:15 amRNSHolding(s) in Company
1st Jul 20245:23 pmRNSExercise of Options, Director Shareholding & TVR
1st Jul 20247:00 amRNSBoard Changes - Appointment of CFO

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.